GOSSAMER BIO, INC. (GOSS) Free cash flow 2018–2025
GOSSAMER BIO, INC. (GOSS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$171.3MFY2025 · since FY2018: -$54.5M → -$171.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$171.3M | -4840.7% |
| FY2024 | -$3.5M | +97.8% |
| FY2023 | -$159.2M | +15.1% |
| FY2022 | -$187.4M | +1.6% |
| FY2021 | -$190.4M | -7.1% |
| FY2020 | -$177.9M | -20.3% |
| FY2019 | -$147.8M | -171.0% |
| FY2018 | -$54.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GOSS financial trends
GOSS RevenueGOSS Net incomeGOSS Net marginGOSS Gross profitGOSS Gross marginGOSS Operating incomeGOSS Operating marginGOSS Operating cash flowGOSS Capital expendituresGOSS Return on equityGOSS Stock buybacksGOSS Dividends paidGOSS Total assetsGOSS Total liabilitiesGOSS Shareholders’ equityGOSS overview →